A/Prof. Peter Psaltis – President, SAHMRI
Peter Psaltis, MBBS (Hons), PhD, FRACP, FCSANZ is an Academic Interventional Cardiologist in the Central Adelaide Local Health Network. He currently holds Level 2 NHMRC Career Development and National Heart Foundation Future Leader Fellowships, and a Faculty position in the Adelaide University Medical School. He is also Deputy Leader of the Heart Health Theme and Co-director of the Vascular Research Centre at the South Australian Health and Medical Research Institute (SAHMRI). A/Prof Psaltis completed his PhD in 2009, studying the cardiovascular reparative properties of immunoselected bone marrow mesenchymal precursor cells, and then undertook a postdoctoral fellowship in vascular adventitial biology as an NHMRC CJ Martin Fellow at the Mayo Clinic, MN, USA (2009-2012). This was followed by an Interventional Cardiology Fellowship at Monash Health, Melbourne (2013-2014), before returning to Adelaide in 2015. In addition to his clinical roles, he leads a bench-to-bedside research program focused on the developmental origins, molecular and pharmacological regulation of macrophages in healthy and diseased vasculature, and the applications of stem and progenitor cells in cardiovascular therapeutics. He has secured $4.8 million dollars in category 1 fellowship and grant funding, including three NHMRC project grants as CIA. He has published >105 full-text manuscripts, is an Associate Editor for Heart, Lung and Circulation and serves on the editorial boards of Cardiovascular Research and Journal of Geriatric Cardiology.
Christina Bursill – Immediate Past President
Christina Bursill started as leader of the Plaque biology and New blood vessel area in January 2017 at the South Australian Health and Medical Research Institute and as a Senior Research Fellow at The University of Adelaide, Department of Health and Medical Science. She recently received the inaugural Lin Huddleston National Heart Foundation fellowship. Dr Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called Chemokines. Christina returned to Australia in 2007 at the Heart Research Institute (HRI) in Sydney where she led the Immunobiology Group. In 2008, Dr Bursill was awarded a National Heart Foundation Career Development Fellowship. At the HRI Dr Bursill developed an interest in high-density lipoproteins (HDL) and through NHMRC/NHF funding investigates novel mechanisms of their action in models of stent biocompatibility, diabetes and wound healing. She also has an interest in using viral gene transfer techniques to over-express proteins that attenuate chemokine activity to suppress atherosclerosis and inflammatory-driven diseases. In 2015 she was awarded the University of Sydney Thompson Fellowship
Professor Stephen Nicholls – Director – Clinical Council Chair
Monash Heart Hospital, VIC
Stephen Nicholls is the Director of Monash Heart and Professor of Cardiology at Monash University. He will be the Director of the Victorian Heart Hospital. He completed his cardiology training at John Hunter Hospital and PhD at the University of Adelaide, prior to holding a postdoctoral fellowship and faculty appointment at the Cleveland Clinic. He returned to Australia to serve as the inaugural Deputy Director and Heart Health Theme Leader at the South Australian Health and Medical Research Institute. His research interests focus on the role of metabolic risk factors and imaging in atherosclerosis, with work spanning from early discovery to leadership of large clinical trials. He is Chair of the (i) Australian Atherosclerosis Society Clinical Council, (ii) Scientific Committee of the Australia and New Zealand Alliance for Cardiovascular Trials, (iii) Asia Pacific Cardiometabolic Consortium and (iv) Future Leader Fellowship committee of the National Heart Foundation, Secretary of the Cardiac Society of Australia and New Zealand, Fellow of the Australian Academy of Health and Medical Sciences and founding board member of the Australian Cardiovascular Alliance.
Dr Joanne Tan – Director
Senior Postdoctoral Researcher
Joanne Tan is a senior postdoctoral researcher with the Heart Health Theme at the South Australian Health & Medical Research Institute. Prior to this, she was at the Heart Research Institute where she investigated the vasculo-protective effects of HDL. Since 2011, her research focusses on the mechanisms underpinning the ability of HDL to regulate angiogenesis. She now seeks to identify novel therapeutic targets to relieve the debilitating effects of diabetic vascular complications.
Dr Mary Kavurma – Secretary – Group Leader, Vascular Complications Group, HRI (NSW)
Mary’s career began with a Bachelor of Science from Macquarie University. She then went on to complete Honours at the University of NSW. Mary completed her PhD at the University of NSW. This work has important implications in advanced atherosclerosis, as smooth muscle cell death can promote plaque instability and rupture. Mary was then awarded a competitive NHMRC CJ Martin fellowship which saw her move to the University of Cambridge for two years where she studied smooth muscle apoptosis, or cell death, in atherosclerosis. In 2009 Mary received a large project grant from the NHMRC to investigate the role of TRAIL in atherosclerosis. This allowed her to employ her first team members. She was appointed group leader in 2012 and the following year the team moved to the HRI.
Dr Natalie Ward – Treasurer
University of Western Australia (WA)
Natalie Ward completed her PhD in 2003 and was awarded the CJ Martin NH&MRC Research Fellowship. Her interests encompass hypertension and cardiovascular disease research and she is currently an Adjunct Senior Lecturer at the University of Western Australia.
Dr Abdul Waheed Khan, Editor
Dr Kahn is a researcher in the field of Epigenetics in diabetes and cardiovascular diseases. His latest work identified the role of exercise induced Epigenetic changes associated with reduced oxidative damage and improved micro vascular phenotype in the elderly. His current interest is to understanding the role of epigenetic mechanisms in diabetes associated atherosclerosis.
Dr Blake Cochran – Director
Blake Cochran is a senior postdoctoral researched at the University of New South Wales. After completing his PhD at the University of Wollongong in 2011, he moved to the Heart Research Institute to undertake postdoctoral training. Since moving to UNSW in 2013, Blake’s work has examined the functional consequences of impaired cholesterol homeostasis in cells involved in the development of diabetes and cardiovascular disease. He was awarded an International Atherosclerosis Society Fellowship to undertake research at Imperial College London in 2017, expanding his work to include immune cells.